17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth

Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells

(2019) Ketan Patel et al.   AAPS PHARMSCITECH

Role of chitosan on controlling the characteristics and antifungal activity of bioadhesive fluconazole vaginal tablets

(2018) Rawan A. Fitaihi et al.   SAUDI PHARMACEUTICAL JOURNAL

Impact of Porous Excipients on the Manufacturability and Product Performance of Solid Self-Emulsifying Drug Delivery Systems

(2018) André O’Reilly Beringhs et al.   AAPS PHARMSCITECH

Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient

(2018) Manali Patki et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Flurbiprofen-Loaded Solid SNEDDS Preconcentrate for the Enhanced Solubility, In-Vitro Dissolution and Bioavailability in Rats

(2018) Rae Kim et al.   Pharmaceutics

Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin

(2017) S. Köllner et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data

(2017) R. Romero et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release

(2017) Ioannis Nikolakakis et al.   Pharmaceutics

Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug

(2016) Muhammad Delwar Hussain et al.   International Journal of Nanomedicine

N,N-Dimethylacetamide Significantly Attenuates LPS- and TNFα-Induced Proinflammatory Responses Via Inhibition of the Nuclear Factor Kappa B Pathway

(2016) Ryan Pekson et al.   MOLECULAR MEDICINE

The epidemiology, etiology, and costs of preterm birth

(2016) Heather A. Frey et al.   Seminars in Fetal & Neonatal Medicine

What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth

(2016) Steve N. Caritis et al.   SEMINARS IN PERINATOLOGY

Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation

(2016) Ali Nasr et al.   Pharmaceutics

Inhibition of Sphingosine Kinase Prevents Lipopolysaccharide-Induced Preterm Birth and Suppresses Proinflammatory Responses in a Murine Model

(2015) Vibhuti Vyas et al.   AMERICAN JOURNAL OF PATHOLOGY

BQ-123 prevents LPS-induced preterm birth in mice via the induction of uterine and placental IL-10

(2015) Nicole S. Olgun et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis

(2014) Erdal Cevher et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Progesterone Pharmacokinetics and Pharmacodynamics With 3 Dosages and 2 Regimens of an Effervescent Micronized Progesterone Vaginal Insert

(2014) Richard J. Paulson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Decidual Neutrophil Infiltration Is Not Required for Preterm Birth in a Mouse Model of Infection-Induced Preterm Labor

(2014) S. F. Rinaldi et al.   JOURNAL OF IMMUNOLOGY

Patients’ administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support

(2014) Angeline N Beltsos et al.   Reproductive Health

N,N-Dimethylacetamide Regulates the Proinflammatory Response Associated with Endotoxin and Prevents Preterm Birth

(2013) Sruthi Sundaram et al.   AMERICAN JOURNAL OF PATHOLOGY

Development of Solid SEDDS, V: Compaction and Drug Release Properties of Tablets Prepared by Adsorbing Lipid-Based Formulations onto Neusilin® US2

(2013) Suhas G. Gumaste et al.   PHARMACEUTICAL RESEARCH

Potential Risks of Pharmacy Compounding

(2013) Jennifer Gudeman et al.   Drugs in research & development

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth

(2013) Alex Vidaeff et al.   Patient Preference and Adherence

Born Too Soon: The global epidemiology of 15 million preterm births

(2013) Hannah Blencowe et al.   Reproductive Health

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection

(2012) John L. Chollet et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus

(2012) L. M. Ensign et al.   Science Translational Medicine

Racial/ethnic disparities in preterm birth: clues from environmental exposures

(2011) Heather H Burris et al.   CURRENT OPINION IN PEDIATRICS

Luteal phase support in assisted reproductive technology treatment: focus on Endometrin® (progesterone) vaginal insert

(2010) Jerome Check   Therapeutics and Clinical Risk Management

The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity

(2009) Stacey Beck et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth

(2009) Francesca Gotsch et al.   Journal of Maternal-Fetal & Neonatal Medicine

Maternal Endotoxin-Induced Preterm Birth in Mice: Fetal Responses in Toll-Like Receptors, Collectins, and Cytokines

(2009) Annamari Salminen et al.   PEDIATRIC RESEARCH